{"lastClose": 6.860000133514404, "len": 1077, "date": "2023-01-23", "alpha_1": -0.09439616266368855, "beta_1": 1.6336051397671632, "drawup_1": 1.5486725887776869, "natr_1": 13.241740919187272, "sup_1": -0.5320699280520398, "res_1": 0.018950476801235704, "bullPattern_1": [], "bearPattern_1": ["SPINNINGTOP"], "rsi_1": 37.38562219425747, "adx_1": 32.47143788386023, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.3123981677255811, "stratHoldAlpha_1": 250.78816619365142, "stratHoldDrawdown_1": -0.6288351122938038, "alpha_3mo": -0.9375927865015665, "beta_3mo": 1.804642897146604, "drawup_3mo": 0.256227773406299, "natr_3mo": 13.241740919187272, "sup_3mo": -0.040330459729168044, "res_3mo": 0.13070938052436293, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 58.55856010660532, "adx_3mo": 42.12201959199031, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -2.3440596351210226, "stratHoldAlpha_3mo": 249.6012116130625, "stratHoldDrawdown_3mo": -0.431644658724621, "Sector": "Health Care", "Country": "United States", "Market Cap": 990002707, "IPO Year": 2018.0, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Name": "Allogene Therapeutics Inc.", "alpha%_1": 0.5453305421909737, "beta%_1": 0.8974618685612512, "drawup%_1": 0.9989855873570518, "natr%_1": 0.9999514955030294, "drawdown%_1": 0.07729169180447962, "stratHoldSharpe%_1": 0.254261593035348, "stratHoldAlpha%_1": 0.15125198608721097, "stratHoldDrawdown%_1": 0.06990545082938439, "alpha%_3mo": 0.04921499046099538, "beta%_3mo": 0.9246478221816586, "drawup%_3mo": 0.5258295321334185, "natr%_3mo": 0.9999421687895401, "drawdown%_3mo": 0.0015572139115228305, "stratHoldSharpe%_3mo": 0.016442900568761437, "stratHoldAlpha%_3mo": 0.0015528651443939263, "stratHoldDrawdown%_3mo": 0.0018288842959559434}